Amongst the BC genes, PALB2 confers non-syndromic quasi-Mendelian susceptibility to BC (BC-risk till age 80 years = 44%) [58], for which equivalent interventions of MRI screening/preventive mastectomy are now offered to mutations carriers and, hence, PALB2 can be incorporated. This evidence concerns the gene PALB2 and breast cancer.